Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.

Salman S, Page-Sharp M, Griffin S, Kose K, Siba PM, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5306-13. doi: 10.1128/AAC.05136-11. Epub 2011 Aug 29.

2.

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.

McGready R, Stepniewska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F.

Eur J Clin Pharmacol. 2006 Dec;62(12):1021-31. Epub 2006 Oct 20. Erratum in: Eur J Clin Pharmacol. 2009 Aug;65(8):847.

PMID:
17053895
3.

Understanding the pharmacokinetics of Coartem.

Djimdé A, Lefèvre G.

Malar J. 2009 Oct 12;8 Suppl 1:S4. doi: 10.1186/1475-2875-8-S1-S4. Review.

4.

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.

Ashley EA, Stepniewska K, Lindegårdh N, McGready R, Annerberg A, Hutagalung R, Singtoroj T, Hla G, Brockman A, Proux S, Wilahphaingern J, Singhasivanon P, White NJ, Nosten F.

Trop Med Int Health. 2007 Feb;12(2):201-8.

5.

Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.

Salman S, Page-Sharp M, Batty KT, Kose K, Griffin S, Siba PM, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2012 Jun;56(6):3288-97. doi: 10.1128/AAC.06232-11. Epub 2012 Apr 2.

6.
7.

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.

Mwesigwa J, Parikh S, McGee B, German P, Drysdale T, Kalyango JN, Clark TD, Dorsey G, Lindegardh N, Annerberg A, Rosenthal PJ, Kamya MR, Aweeka F.

Antimicrob Agents Chemother. 2010 Jan;54(1):52-9. doi: 10.1128/AAC.00679-09. Epub 2009 Oct 19.

8.

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

Kredo T, Mauff K, Van der Walt JS, Wiesner L, Maartens G, Cohen K, Smith P, Barnes KI.

Antimicrob Agents Chemother. 2011 Dec;55(12):5616-23. doi: 10.1128/AAC.05265-11. Epub 2011 Sep 26.

9.

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.

Lefèvre G, Bhad P, Jain JP, Kalluri S, Cheng Y, Dave H, Stein DS.

Malar J. 2013 Sep 8;12:312. doi: 10.1186/1475-2875-12-312.

10.

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.

Staehli Hodel EM, Guidi M, Zanolari B, Mercier T, Duong S, Kabanywanyi AM, Ariey F, Buclin T, Beck HP, Decosterd LA, Olliaro P, Genton B, Csajka C.

Malar J. 2013 Jul 10;12:235. doi: 10.1186/1475-2875-12-235.

11.

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.

Hietala SF, Mårtensson A, Ngasala B, Dahlström S, Lindegårdh N, Annerberg A, Premji Z, Färnert A, Gil P, Björkman A, Ashton M.

Antimicrob Agents Chemother. 2010 Nov;54(11):4780-8. doi: 10.1128/AAC.00252-10. Epub 2010 Aug 16.

12.

Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.

Abdulla S, Amuri B, Kabanywanyi AM, Ubben D, Reynolds C, Pascoe S, Fitoussi S, Yeh CM, Nuortti M, Séchaud R, Kaiser G, Lefèvre G.

Malar J. 2010 Sep 3;9:253. doi: 10.1186/1475-2875-9-253.

13.

A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R.

Am J Trop Med Hyg. 2001 May-Jun;64(5-6):247-56.

PMID:
11463111
14.

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.

Byakika-Kibwika P, Lamorde M, Mayito J, Nabukeera L, Namakula R, Mayanja-Kizza H, Katabira E, Ntale M, Pakker N, Ryan M, Hanpithakpong W, Tarning J, Lindegardh N, de Vries PJ, Khoo S, Back D, Merry C.

J Antimicrob Chemother. 2012 Sep;67(9):2213-21. doi: 10.1093/jac/dks207. Epub 2012 Jun 11.

15.

Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.

Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S; B2303 Study Group..

Antimicrob Agents Chemother. 2011 Sep;55(9):3994-9. doi: 10.1128/AAC.01115-10. Epub 2011 Jun 13. Erratum in: Antimicrob Agents Chemother. 2012 Oct;56(10):5429. Klouwenberg, P K [corrected to Klein Klouwenberg, P].

16.

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.

Lefèvre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D.

Br J Clin Pharmacol. 2002 Nov;54(5):485-92.

17.

Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.

Nyunt MM, Nguyen VK, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Mwima MW, Achan J, Aweeka F, Parikh S, Mwebaza N.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1274-82. doi: 10.1128/AAC.01605-15.

18.

The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.

Borrmann S, Sallas WM, Machevo S, González R, Björkman A, Mårtensson A, Hamel M, Juma E, Peshu J, Ogutu B, Djimdé A, D'Alessandro U, Marrast AC, Lefèvre G, Kern SE.

Trop Med Int Health. 2010 Apr;15(4):434-41. doi: 10.1111/j.1365-3156.2010.02477.x. Epub 2010 Feb 17.

19.

Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.

Mosha D, Guidi M, Mwingira F, Abdulla S, Mercier T, Decosterd LA, Csajka C, Genton B.

Antimicrob Agents Chemother. 2014 Aug;58(8):4583-92. doi: 10.1128/AAC.02595-14. Epub 2014 May 27.

20.

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.

German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):424-9. doi: 10.1097/QAI.0b013e3181acb4ff.

PMID:
19506482

Supplemental Content

Support Center